43
Growth Score
pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4019651
Biomay AG is a privately held company .
About the Company
Biomay has assembled an impressive pipeline of innovative products for immunotherapy of allergic diseases based on its proprietary technology platforms.
The IgE immune apheresis device IgEnio®, co-developed with Fresenius Medical Care, has achieved CE mark designation and is currently actively marketed in several European countries. Additional
clinical studies are underway to broaden the scope of applications for this unique product.
The most advanced peptide carrier fusion allergy vaccine BM32, indicated for grass pollen allergy, has completed phase IIb of clinical development and is ready for phase III pivotal Trials.
